JD Health International Inc.
6618
Classifica tra le azioni
#1403
JD Health International Inc., functioning as an investment holding entity, runs... JD Health International Inc., functioning as an investment holding entity, runs an expansive digital healthcare platform across the People's Republic of China. The company supplies a diverse range of pharmaceutical and wellness products, such as over-the-counter and prescription medications, medical devices, and health supplements. These goods are distributed through both direct sales and an extensive online retail pharmacy network. Beyond product offerings, its comprehensive service suite includes virtual medical consultations, patient referrals to hospitals and doctors, health screening programs, genetic testing, and beauty care services. Additionally, it develops intelligent healthcare and wellness management solutions, alongside providing technical support and advertising services. The platform also facilitates access to various medical provisions, including general health examinations, cosmetic medical procedures, vaccination bookings, dental treatments, and nucleic acid testing. Incorporated in 2018 and headquartered in Beijing, People's Republic of China, JD Health International Inc. is a subsidiary of JD Jiankang Limited.
Prezzo delle azioni
$4.98
Capitalizzazione di mercato
$15.88B
Variazione (1 giorno)
-2.26%
Variazione (1 anno)
-39.80%
Paese
CN
Scambia JD Health International Inc. (6618)
Categoria
Healthcare
Utile per JD Health International Inc. (6618)
Utile nel Jun 2026 TTM: $1.07B
Secondo gli ultimi rapporti finanziari di JD Health International Inc., gli utili attuali della società sono $1.07B. Nel 2023, la società ha registrato un utile di $380.49M, un aumento rispetto a agli utili del 2022, che erano di $100.87M. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Storico degli utili di JD Health International Inc. dal 2017 al 2026
Utile alla fine di ogni anno
| Anno | Utile | Cambia |
|---|---|---|
| 2026 (TTM) | $1.07B | 62.26% |
| 2024 | $657.16M | 72.71% |
| 2023 | $380.49M | 277.20% |
| 2022 | $100.87M | -171.12% |
| 2021 | $-141.84M | -94.57% |
| 2020 | $-2.61B | 2,080.12% |
| 2019 | $-119.87M | -369.26% |
| 2018 | $44.52M | 13.15% |
| 2017 | $39.34M | 0.00% |
Utile per aziende simili o concorrenti
| Azienda | Utile | Differenza negli utili | Il paese |
|---|---|---|---|
| $9.87B | 825.69% |
US
|
|
| - | - |
DE
|
|
| $3.87B | 262.46% |
US
|
|
| $687.82M | -35.50% |
SA
|
|
| $1.25B | 16.92% |
BR
|
